Compound 7d is a dual-targeting antibacterial agent that potently inhibits both DNA topoisomerase IV (IC50 = 0.23 µM) and DNA gyrase. It demonstrates in vitro efficacy against Staphylococcus aureus and Escherichia coli, making it a valuable tool for researching novel antibiotics and bacterial enzyme mechanisms.